The use of a side effect as a qualitative indicator of plasma chlorpromazine levels

Author： Chetty M. Gouws E. Miller R. Moodley S.

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.9, Iss.1, 1999-01, pp. : 77-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine

By Tada Miho Shirakawa Kiyoharu Matsuoka Nobuya Mutoh Seitaro

Psychopharmacology, Vol. 176, Iss. 1, 2004-10 ,pp. : 94-100

Springer Publishing Company

Access to resources Recommend Favorite

Response in chronic schizophrenia correlated with chlorpromazine, 7-OH-chlorpromazine and chlorpromazine sulfoxide levels

By Chetty M. Pillay V.L. Moodley S.V. Miller R.

European Neuropsychopharmacology, Vol. 6, Iss. 2, 1996-05 ,pp. : 85-91

Elsevier

Access to resources Recommend Favorite

Modelling a Spontaneously Reported Side Effect by Use of a Markov Mixed-Effects Model

By Zingmark Per-Henrik Kågedal Matts Karlsson Mats

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 32, Iss. 2, 2005-04 ,pp. : 261-281

Springer Publishing Company

Access to resources Recommend Favorite

The effect of sublingual captopril versus intravenous enalaprilat on angiotensin II plasma levels

By Onzenoort Hein Bussink Michiel Menheere Paul Mook Walther Kuy Paul-Hugo

Pharmacy World and Science, Vol. 28, Iss. 3, 2006-06 ,pp. : 131-134

Springer Publishing Company

Access to resources Recommend Favorite

Relationship between plasma and brain levels and the anticonvulsant effect of lamotrigine in rats

By Castel-Branco M. Lebre V. Falcao A. Figueiredo I. Caramona M.

European Journal of Pharmacology, Vol. 482, Iss. 1, 2003-12 ,pp. : 163-168

Elsevier

Access to resources Recommend Favorite